Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study

Cancer Immunology, Immunotherapy · Published 2023-11-01 · Available online 28 Aug 2023 · Journal article · DOI 10.1007/s00262-023-03522-3 · PMID: 37638980 · PMC · Cited by 25 (Crossref)

Authors (28)

Melissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, Alessandro Parisi, Marcello Tiseo, Paola Bordi, Maria Michiara, Simona Bui, Agnese Cosenza, Leonarda Ferri, Giulia Claire Giudice, Irene Testi, Elena Rapacchi, Roberta Camisa, Bruno Vincenzi, Giuseppe Caruso, Antonio Natale Rauti, Federica Arturi, Marco Tucci, Valentina Santo, Valentina Ricozzi, Vanessa Burtet, Paolo Sgargi, Renata Todeschini, Fable Zustovich, Luigia Stefania Stucci, Daniele Santini, Sebastiano Buti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

72

Issue

11

Pages

3707-3716

Year

2023

Citation

Bersanelli, M., Cortellini, A., Leonetti, A., et al. (2023). Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03522-3

Related articles

• Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysis · International Journal of Clinical Oncology · 2026 · Cites or is cited by this article
• The immunomodulatory role of vitamins in tumor: Mechanisms and therapeutic implications · PHARMACOLOGICAL RESEARCH · 2026 · Cites or is cited by this article
• Non-pharmacological Supportive Care Interventions during Immunotherapy for People with Cancer: A Systematic Scoping Review and Future Directions · Current Oncology Reports · 2025 · Cites or is cited by this article
• Vitamin D should be considered as a targeted therapy in glioblastoma cases · Forum of Clinical Oncology · 2026 · Cites or is cited by this article
• Seasonal timing of anti–PD-1 therapy and survival outcomes in a real-world pan-cancer cohort · Expert Review of Clinical Immunology · 2026 · Cites or is cited by this article
• HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal

Metrics

Citations (Crossref)

25